Posts Tagged ‘antipsychotics’

About Antipsychotics

Wednesday, March 3rd, 2010

One of the most common reasons for noncompliance and discontinued use of antipsychotic medication is weight gain. The agent believed to be responsible for the increased food intake of patients taking antipsychotics is the serotonin blocker.

Conventional anti-psychotics include the following:

* Haloperidol (Haldol®, Peridol®)
* Molindone (Moban®)
* Thioridazine (Apo-Thioridazine®, Mellaril®, Novo-Ridazine®, PMS-Thioridazine®)
* Newer antipsychotics, classified as atypical antipsychotics, include the following:
* Clozapine (Clozaril®)
* Olanzapine (Zyprexa®)
* Quetiapine (Seroquel®)
* Risperidone (Risperdal®)
* Sertindole (Serlect®)
* Ziprasidone (Seldox®)

Haloperidol (Haldol®, Peridol®) is a conventional antipsychotic with a lower incidence of weight gain than the newer agents clozapine (Clozaril®), olanzapine (Zyprexa®), and sertindole (Serlect®).

A retrospective study showed that clozapine (Clozaril®) and olanzapine (Zyprexa®) had the greatest associated weight gain, followed by intermediate weight gain with risperidone (Risperdal®).

Patients treated with sertindole (Serlect®) had less weight gain than those treated with haloperidol. Another study linked clozapine (Clozaril®) to significant weight gain and lipid abnormalities, suggesting increased risk for diabetes.

Among the conventional antipsychotics, thioridazine and chlorpromazine have greater potential for weight gain, while molindone (Moban®) is the only antipsychotic shown not to increase weight on a consistent basis.

Studies show that antipsychotic agents have an effect on the reproductive hormones. Women receiving antipsychotics tended to display hyperprlactinemia and tended to be hypoestrogenic. Women with primary obesity did not have hyperprolactinemia and tended to have normal or elevated estradiol serum levels. These differences have pathogenic and therapeutic implications besides the effects on gonadal and adrenal steroids. Prolactin alone promotes appetite and insulin resistance that may underlie the excessive body weight observed in hyperprolactinemic conditions detected in both animal and clinical studies.

buy cheap paxil antidepressant no prescription drugs
FedEx overnight shipping no prescription drugs online pharmacy

CMS Announces No Changes for Antidepressant and Antipsychotic Access

Tuesday, March 31st, 2009

The Medicare program announced it would not reevaluate for the 2010 calendar year the 2 psychiatric drug categories protected under Part D “all or substantially all.” Seniors who need antidepressants and antipsychotics will still be able to get “all or substantially all” of the chemically distinct drugs offered in those 2 categories.

Congress passed a law last summer that instructed Medicare to re­evaluate the 6 protected Part D categories—of which 2 are antide­pres- ­sants and antipsychotics.

The Medicare Improvements for Patients and Providers Act (MIPPA) requires the Centers for Medicare and Medicaid Services (CMS) to ensure that all 6 categories meet 2 standards. If they fail to do so, they would be dropped from their protected status in 2010. The CMS can also use the 2 standards to designate new protected drug categories. The MIPPA requires the CMS to identify protected categories or classes of drugs in which “access to multiple drugs within a category or class” is needed and in which “major or life-threatening clinical consequences” may arise if access is restricted.

An interim final rule that the CMS published on January 16 (just days before the Obama administration took office) held that there was too little time to make changes by 2010. Psychiatric patients in Part D plans will therefore continue to have access to all antidepressants and antipsychotics in 2009 and 2010—and perhaps beyond—depending on how long the CMS analysis takes. The FDA defines chemically distinct drugs as therapeutic equivalents identified as such in the FDA’s Orange Book.

Psychiatric groups had hoped the 2 new standards would allow additional psychopharmacological categories to be added to antidepressants and antipsychotics as protected.

That may, in fact, turn out to be the case. In its Federal Register notice, the CMS indicated that the 2 standards “will likely expand access to drugs for certain classes or categories and provide greater inclusion of manufacturers’ drugs associated with those classes or categories.

buy cheap paxil antidepressant no prescription drugs
FedEx overnight shipping no prescription drugs online pharmacy